PMR lab studies by ⁦@anisha_dua⁩ ⁦@RheumNow⁩ #RNL2023 Majority of patients will have elevated inflammatory markers. Rapid clinical response to low dose of steroid. https://t.co/AgdIJ5YbOu

Some points to consider in relapsing PMR , by ⁦@anisha_dua⁩ ⁦@RheumNow⁩ #RNL2023 Elevated ESR and CRP rule out GCA. Relapses are common with steroid tapering, especially below 5mg. https://t.co/D17mdly7z5

Long live the GOAT Rx: MTX 🐐🐐 History of usage dating back to 1950 Use 1st-line Optimize dose Supplement folic acid Split dose Give SQ Use in combination therapy Dr Joel Kremer #RNL2023 @RheumNow https://t.co/CCBvQoNHXo

#ClinicalPearl #Methotrexate weekly May reduce side effects in rapidly dividing cells vs using it daily or every few days. GI, oral, bone marrow side effects should be less if once a week. Joel Kremer ⁦@RheumNow⁩ #RNL2023 https://t.co/i0LZoQuK0w

TYK2 signalling Vs JAK signalling summary #RNL2023 https://t.co/0VNBiEc6jq

Approach to pregnancy in patients with PsA , By Dr.Chambers #RNL2023 ⁦@RheumNow⁩ https://t.co/8tSz7qbmQU

Prevalence of PsA in women of reproductive age, By Dr.Chambers #RNL2023 ⁦@RheumNow⁩ https://t.co/hB6QQtz7fw

Dr. Laura Coates on PsA treatment: - Applying treat to target associated with better quality of life - low disease activity is a reasonable target Do you use PROs in managing your PsA pts? Perhaps we should @RheumNow #RNL2023 https://t.co/36n1Cp5jtP

Why do PROs matter? @DrLauraCoates reviewed this slide regarding the increased survival curve in end-stage cancer patients when we monitor PROs. @RheumNow #RNL2023 https://t.co/JfHNBKJGRl

Dr.Robert Spiera approach to GCA #RNL2023 ⁦@RheumNow⁩ https://t.co/ublzYwBbIF

Steroid sparing agents in GCA , what worked? By Dr.Robert Spiera #RNL2023 ⁦@RheumNow⁩ https://t.co/7Q9UYRSAhR

PMR by ⁦@anisha_dua⁩ ⁦@RheumNow⁩ #RNL2023 https://t.co/mHIBqqRUWh

How is a biosimilar approved? Comparative effectiveness study for the reason that the medication was initial approved required, not for other indications Jonathan Kay shows ex of ETN-ykro vs reference ETN in RA Non-inferior in immunogenicity, safety, efficacy @RheumNow #RNL2023 https://t.co/OOHie9Qr5t

Great #RNL2023 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversary of going into coma "I am the expert on what this virus can do. I don't want the world to ever forget" @RheumNow https://t.co/kTuDXDhTtQ

Tremendously emotional (and unfiltered) first person account of his fight with COVID-19 by Miracle Larry who thanked our Dr. Cush @RheumNow for his ingenuity in fighting COVID-19, thanking healthcare workers for all they do, and reminding us to be empathic. #RNL2023 https://t.co/i0D7r8dR8n